Enliven Therapeutics (ELVN) Q1 2021 Earnings

11MayExpected
Q2 2020
Q3 2020
Q4 2020
Q1 2021
-2.32
-1.73
-1.15
-0.56

Details

Expected EPS
-0.835
Actual EPS
-2.32
Surprise EPS
-1.48
Surprise Percent
+177.84%

Description

Enliven Therapeutics (ELVN) has reported earnings of -2.32 per share for Q1 2021.

0 Comments

Share your thoughts